BioSpace, Inc.
Job Details
About Civica:
Critical shortages of essential generic injectable drugs are an ongoing crisis in U.S. healthcare and have reached an all-time high. Over 300 essential medications are currently reported to be in shortage, according to industry and FDA reports.
Shortages put patients at risk and waste hospital resources.
Civica is a market-based nonprofit solution created in 2018 by health systems and philanthropies for the express purpose of preventing and mitigating drug shortages. Today, nearly 60 health systems have joined Civica, representing over 1,400 hospitals and approximately one-third of all U.S. hospital beds. Civica has also supplied the U.S. Department of Veteran's Affairs, the U.S. Department of Defense and the U.S. Strategic National Stockpile with essential medicines. Civica currently supplies medicines to health system members in 49 states.
Civica's mission has expanded beyond the hospital setting to reach consumers directly through CivicaScript, which is dedicated to making quality outpatient generic medicines affordable and available. CivicaScript works with trusted manufacturing partners to develop quality generic medicines and has forged partnerships with like-minded payors, pharmacy benefit managers and pharmacies to enable significant cost savings to be passed along to their customers.
Civica's new 140,000 square foot state-of-the-art manufacturing facility in Virginia will soon produce a steady supply of more than three dozen sterile injectables, all drugs that are currently in or near shortage. The plant will also produce affordable biosimilar insulins, ensuring all Americans have access to lower cost, quality insulins, regardless of their insurance status.
The Civica Foundation is a 501(c)(3) organization that fosters philanthropic support for Civica's work to manufacture and distribute affordable medications. The Foundation's first commitment is to support Civica's efforts to bring affordable insulin to all Americans. Leaders from nearly every corner of the diabetes ecosystem are partners in this initiative.
Civica is leading a movement for patients, not profits. Because eliminating shortages and stabilizing high prices are in the best interest of patients.
Join us. Learn more at
www.civicarx.org
Position Summary
The Validation Engineer II will be responsible for leading the commissioning, qualification, and validation (CQV) to support the commissioning, qualification, and validation of new and modified equipment, facilities, utilities, products, and processes in support of the project, operations, and quality objectives. Working closely with system owners and related stakeholders (Operations, Engineering, Laboratories, IT, and Quality Assurance). This role will guide CQV activities to a compliant state throughout their lifecycle. This includes authoring, reviewing, and executing related CQV documentation as well as related documents for the role (e.g., procedures and change control records). Serves as subject matter expert for CQV activities.
Essential Duties and Responsibilities: Lead the development and execution of commissioning, qualification, and validation protocols for various equipment and systems. Responsible for all phases of the CQV activity, including requirements gathering, validation planning, protocol generation, test execution, configuration documentation, and system release. Executes validation activity in a timely manner, planning and proactively pursuing details to ensure project completion without avoidable delays. Evaluate System Change Controls for Validation Impact. Support Change Qualification through the creation of relevant Change Actions. Support the development of Standard Operating Procedures for new processes and equipment. Interpersonal skills to manage interactions and achieve results across a range of functions within the site. It may also extend to external communication with system vendors. Serve as Principal Investigator for validation-related excursions. Contribute to the continuous improvement of validation processes and procedures. Basic Qualifications and Capabilities:
Bachelor's degree in engineering or relevant sciences and 8+ years of CQV experience. 8 years' experience with sterile injectables, combo-devices, or biologics. Advanced degrees or certifications relevant to the role is a plus. Knowledge of regulatory requirements (cGMP, FDA, etc.). Experience authoring, approving, and executing validation protocols for major pharmaceutical manufacturing facilities, utilities, and equipment. Self-directed with problem-solving, analytical, and technical skills. Ability to think strategically and tactically (detail-oriented). Strong collaborative and influencing skills and ability to work well in a cross-functional, matrixed environment. Ability to lead, take ownership, and follow through on assigned projects. Demonstrated ability to work in a fast-paced team environment, meet deadlines, and prioritize work. Experience in a process improvement environment, including change management and participating in Lean/Six Sigma project teams. Ability to work autonomously within established guidelines, procedures, and practices. Preferred Qualifications:
Experience in a sterile fill-finish facility. Experience with single-use components in drug product formulation, sterile filtration, and aseptic filling applications. Start-up experience preferred. Experience with validation tools and processes, including temperature mapping and use of Kaye Validator. Company
Civica Rx is the nonprofit solution for reliable supplies of quality generic medications. Established by U.S. member hospitals and philanthropic organizations, Civica is the only pharmaceutical company created for the express purpose of preventing and mitigating drug shortages, ensuring the affordable supply of essential medications used in America's ERs, ICUs and during surgeries. As of January 2025, Civica has provided more than 200 million units of medications to help treat over 90 million patients.
Civica is making significant progress in bringing its new state-of-the-art Virginia sterile injectable manufacturing facility online. This facility will produce a steady supply of more than three dozen drugs currently in or near shortage status. It will also produce affordable biosimilar insulins, ensuring all Americans have access to lower cost, quality insulins, regardless of their insurance status.
The growing team on site is completing the various qualification and regulatory steps needed to bring each of the facility's existing filling lines - one for vials and another for pre-filled syringes - to full operation and is installing a third line that will supply pre-filled pen cartridges. Combined, these three production lines will produce more than 200 million units annually, which will tremendously impact the availability and cost of these medicines throughout the country.
Company info Website https://civicarx.org/ Location 1 Civica Way Petersburg VA 23805 United States
Share this job
Facebook Twitter LinkedIn
About Civica:
Critical shortages of essential generic injectable drugs are an ongoing crisis in U.S. healthcare and have reached an all-time high. Over 300 essential medications are currently reported to be in shortage, according to industry and FDA reports.
Shortages put patients at risk and waste hospital resources.
Civica is a market-based nonprofit solution created in 2018 by health systems and philanthropies for the express purpose of preventing and mitigating drug shortages. Today, nearly 60 health systems have joined Civica, representing over 1,400 hospitals and approximately one-third of all U.S. hospital beds. Civica has also supplied the U.S. Department of Veteran's Affairs, the U.S. Department of Defense and the U.S. Strategic National Stockpile with essential medicines. Civica currently supplies medicines to health system members in 49 states.
Civica's mission has expanded beyond the hospital setting to reach consumers directly through CivicaScript, which is dedicated to making quality outpatient generic medicines affordable and available. CivicaScript works with trusted manufacturing partners to develop quality generic medicines and has forged partnerships with like-minded payors, pharmacy benefit managers and pharmacies to enable significant cost savings to be passed along to their customers.
Civica's new 140,000 square foot state-of-the-art manufacturing facility in Virginia will soon produce a steady supply of more than three dozen sterile injectables, all drugs that are currently in or near shortage. The plant will also produce affordable biosimilar insulins, ensuring all Americans have access to lower cost, quality insulins, regardless of their insurance status.
The Civica Foundation is a 501(c)(3) organization that fosters philanthropic support for Civica's work to manufacture and distribute affordable medications. The Foundation's first commitment is to support Civica's efforts to bring affordable insulin to all Americans. Leaders from nearly every corner of the diabetes ecosystem are partners in this initiative.
Civica is leading a movement for patients, not profits. Because eliminating shortages and stabilizing high prices are in the best interest of patients.
Join us. Learn more at
www.civicarx.org
Position Summary
The Validation Engineer II will be responsible for leading the commissioning, qualification, and validation (CQV) to support the commissioning, qualification, and validation of new and modified equipment, facilities, utilities, products, and processes in support of the project, operations, and quality objectives. Working closely with system owners and related stakeholders (Operations, Engineering, Laboratories, IT, and Quality Assurance). This role will guide CQV activities to a compliant state throughout their lifecycle. This includes authoring, reviewing, and executing related CQV documentation as well as related documents for the role (e.g., procedures and change control records). Serves as subject matter expert for CQV activities.
Essential Duties and Responsibilities: Lead the development and execution of commissioning, qualification, and validation protocols for various equipment and systems. Responsible for all phases of the CQV activity, including requirements gathering, validation planning, protocol generation, test execution, configuration documentation, and system release. Executes validation activity in a timely manner, planning and proactively pursuing details to ensure project completion without avoidable delays. Evaluate System Change Controls for Validation Impact. Support Change Qualification through the creation of relevant Change Actions. Support the development of Standard Operating Procedures for new processes and equipment. Interpersonal skills to manage interactions and achieve results across a range of functions within the site. It may also extend to external communication with system vendors. Serve as Principal Investigator for validation-related excursions. Contribute to the continuous improvement of validation processes and procedures. Basic Qualifications and Capabilities:
Bachelor's degree in engineering or relevant sciences and 8+ years of CQV experience. 8 years' experience with sterile injectables, combo-devices, or biologics. Advanced degrees or certifications relevant to the role is a plus. Knowledge of regulatory requirements (cGMP, FDA, etc.). Experience authoring, approving, and executing validation protocols for major pharmaceutical manufacturing facilities, utilities, and equipment. Self-directed with problem-solving, analytical, and technical skills. Ability to think strategically and tactically (detail-oriented). Strong collaborative and influencing skills and ability to work well in a cross-functional, matrixed environment. Ability to lead, take ownership, and follow through on assigned projects. Demonstrated ability to work in a fast-paced team environment, meet deadlines, and prioritize work. Experience in a process improvement environment, including change management and participating in Lean/Six Sigma project teams. Ability to work autonomously within established guidelines, procedures, and practices. Preferred Qualifications:
Experience in a sterile fill-finish facility. Experience with single-use components in drug product formulation, sterile filtration, and aseptic filling applications. Start-up experience preferred. Experience with validation tools and processes, including temperature mapping and use of Kaye Validator. Company
Civica Rx is the nonprofit solution for reliable supplies of quality generic medications. Established by U.S. member hospitals and philanthropic organizations, Civica is the only pharmaceutical company created for the express purpose of preventing and mitigating drug shortages, ensuring the affordable supply of essential medications used in America's ERs, ICUs and during surgeries. As of January 2025, Civica has provided more than 200 million units of medications to help treat over 90 million patients.
Civica is making significant progress in bringing its new state-of-the-art Virginia sterile injectable manufacturing facility online. This facility will produce a steady supply of more than three dozen drugs currently in or near shortage status. It will also produce affordable biosimilar insulins, ensuring all Americans have access to lower cost, quality insulins, regardless of their insurance status.
The growing team on site is completing the various qualification and regulatory steps needed to bring each of the facility's existing filling lines - one for vials and another for pre-filled syringes - to full operation and is installing a third line that will supply pre-filled pen cartridges. Combined, these three production lines will produce more than 200 million units annually, which will tremendously impact the availability and cost of these medicines throughout the country.
Company info Website https://civicarx.org/ Location 1 Civica Way Petersburg VA 23805 United States
Share this job
Facebook Twitter LinkedIn